Predictions
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€3.44
08.02.21
08.02.21
€5.00
08.02.22
08.02.22
-27.31%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year
Star Equity Holdings Inc.
Start price
Target price
Perf. (%)
€3.12
08.02.21
08.02.21
€5.00
08.02.22
08.02.22
14.10%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€32.25
08.02.21
08.02.21
€50.00
08.02.22
08.02.22
6.98%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year
Nuwellis Inc.
Start price
Target price
Perf. (%)
€7.35
08.02.21
08.02.21
€9.00
08.02.22
08.02.22
-1.36%
22.02.21
22.02.21
Could be very worthwhile Investment >20% year
Overstock.com
Start price
Target price
Perf. (%)
€79.50
08.02.21
08.02.21
-
08.02.22
08.02.22
-13.48%
27.07.21
27.07.21
Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
eHealth Inc.
Start price
Target price
Perf. (%)
€48.35
08.02.21
08.02.21
-
08.02.22
08.02.22
16.56%
24.03.21
24.03.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Synaptics Inc.
Start price
Target price
Perf. (%)
€98.50
08.02.21
08.02.21
-
08.02.22
08.02.22
17.77%
24.03.21
24.03.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Gamestop Corp.
Start price
Target price
Perf. (%)
€14.13
08.02.21
08.02.21
-
-36.12%
21.02.21
21.02.21
Could be very worthwhile Investment >20% year
AMC Entertainment Holdings Inc.
Start price
Target price
Perf. (%)
€5.90
08.02.21
08.02.21
-
08.02.22
08.02.22
-20.34%
10.02.21
10.02.21
Could be very worthwhile Investment >20% year
Some uniques
Known brand
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€22.22
08.02.21
08.02.21
-
08.02.22
08.02.22
-2.61%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year
Small cyclical dependencies
International Flavors & Fragrances Inc.
Start price
Target price
Perf. (%)
€91.86
08.02.21
08.02.21
-
08.02.22
08.02.22
-
08.02.21
08.02.21
Risky Investment
Zynga Inc.
Start price
Target price
Perf. (%)
€9.00
07.02.21
07.02.21
€10.00
07.02.22
07.02.22
-30.00%
01.11.21
01.11.21
Capable Management
Very low/no dividend yield expected
Risky balance sheet
Few uniques
Stericycle Inc.
Start price
Target price
Perf. (%)
€57.18
07.02.21
07.02.21
-
07.02.22
07.02.22
5.35%
21.06.21
21.06.21
Probably not worthwhile Investment
Low dividend yield expected
Seelos Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.88
07.02.21
07.02.21
€5.00
07.02.22
07.02.22
-66.49%
08.02.22
08.02.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Marin Software
Start price
Target price
Perf. (%)
€2.30
07.02.21
07.02.21
€10.00
07.02.22
07.02.22
20.00%
08.02.22
08.02.22
Could be very worthwhile Investment >20% year
Very small cyclical dependencies
Moderna Inc.
Start price
Target price
Perf. (%)
€143.50
07.02.21
07.02.21
-
07.02.22
07.02.22
0.42%
20.02.21
20.02.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Gamestop Corp.
Start price
Target price
Perf. (%)
€14.13
07.02.21
07.02.21
-
07.02.22
07.02.22
-27.69%
16.02.21
16.02.21
Risky Investment
overvalued
Outdated or very high risk business model
High risks in the balance sheet
AMC Entertainment Holdings Inc.
Start price
Target price
Perf. (%)
€5.90
07.02.21
07.02.21
-
07.02.22
07.02.22
-22.03%
16.02.21
16.02.21
overvalued
Outdated or very high risk business model
Risky Investment
Significant cyclical dependencies
Greenhill & Co.inc.
Start price
Target price
Perf. (%)
€13.00
06.02.21
06.02.21
€15.00
06.02.22
06.02.22
20.00%
05.12.21
05.12.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
T2 Biosystems Inc.
Start price
Target price
Perf. (%)
€137.50
06.02.21
06.02.21
€150.00
06.02.22
06.02.22
-67.82%
12.08.21
12.08.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
High valuation
MaxCyte Inc
Start price
Target price
Perf. (%)
€10.00
06.02.21
06.02.21
€10.00
06.02.22
06.02.22
33.00%
12.08.21
12.08.21
Capable Management
Future proof or reliable business model
Higher risks for its business
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€416.00
06.02.21
06.02.21
-
06.02.22
06.02.22
7.91%
25.05.21
25.05.21
EBIT growth >5% per year expected
Very low/no dividend yield expected
Fifth Third Bancorp
Start price
Target price
Perf. (%)
€26.60
06.02.21
06.02.21
-
06.02.22
06.02.22
41.35%
13.12.21
13.12.21
Very high dividend yield expected
Business model of the past or high risk
Higher risks for its business